All lobbying filings

CROSSROADS STRATEGIES, LLC

Lobbying for VERTEX PHARMACEUTICALS INCORPORATED · biopharmaceutical company

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate · $30,000.00 income · posted Oct 19, 2025

Official filing document

Bills named in this filing 2

S 475
Alternatives to PAIN Act
HR 1227
Alternatives to PAIN Act

Lobbying activity 3

Health Issues

General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Education about non-opioid pain therapies.H.R.1227/S.475 Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act.

Medical/Disease Research/Clinical Labs

General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Education about precision medicine.

Medicare/Medicaid

General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Education about the importance of access to non-opioid pain therapies for Medicare beneficiaries. H.R.1227/S.475 Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.